Diambra and colleagues1 integrated metabolic dysfunction-associated steatotic liver disease phenotypes with proteomics to derive a four-protein mortality score (PS4: FTCD, FABP1, ADGRG1 and GAST). We ...
Risk stratification in compensated advanced chronic liver disease has traditionally been based on the identification of ...
We read with great interest the commentary by Benson Massey, which raises concerns about the recent widespread use of glucagon-like peptide-1 (GLP-1) agonists.1 We offer an alternative perspective and ...
Background SIRT6 acts as a tumour suppressor in multiple cancers by regulating glucose and lipid metabolism, but its role in intrahepatic cholangiocarcinoma (ICC) remains unclear. Objective We ...
Background and aims RNA interference has been extensively explored in patients with chronic hepatitis B (CHB) infection. We aimed to characterise the long-term efficacy of small interfering RNA (siRNA ...
1 Institute of Digestive Disease and Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China 2 Department of Surgery, ...
Correspondence to Dr Michael J Bourke, Department of Gastroenterology and Hepatology, Westmead Hospital, Westmead 2145, New South Wales, Australia; michael{at}citywestgastro.com.au Background and aims ...
Objective The cross-immunogenicity of the recently approved infliximab-biosimilar Remsima (CT-P13) with the originator drug Remicade is still unknown. Design Sera of patients with IBD with or without ...
4 Department of Oncology, University of Cambridge, Hutchison/MRC Research Centre, Hills Road, Cambridge, UK Correspondence to Ashraf E K Ibrahim, Department of Pathology, Division of Molecular ...
Correspondence to Dr Barham K Abu Dayyeh, Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R), Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, ...
Correspondence to Dr Massimiliano di Pietro, MRC Cancer Unit, University of Cambridge, Cambridge Biomedical Campus, P.O. Box 197, Cambridge CB2 0XZ, UK; md460{at}mrc-cu.cam.ac.uk The most recent ...
Correspondence to Shumei Song, Departmental of GI Medical Oncology, U.T.MD. Anderson Cancer Center, Houston, TX 77030, USA; ssong{at}mdanderson.org; Jaffer A Ajani ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results